Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Vedolizumab in adults with Ulcerative colitis or Crohn's disease in the community setting; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 4 | Status: RECRUITING